Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel pairwise sequence alignment algorithm for similarity search in massive datasets.

Briefings in bioinformatics·2025
Same author

Interpretable deep residual network uncovers nucleosome positioning and associated features.

Nucleic acids research·2024
Same author

A fuzzy logic-based computational method for the repurposing of drugs against COVID-19.

BioImpacts : BI·2022
See all related articles

Related Experiment Video

Updated: Dec 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.0K

Computational-based drug repurposing methods in COVID-19.

Yosef Masoudi-Sobhanzadeh1

  • 1Laboratory of Systems Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Bioimpacts : BI
|August 15, 2020
PubMed
Summary

Drug repurposing offers a faster way to find COVID-19 treatments. This approach identifies existing drugs for new uses, overcoming challenges in developing novel medications for the novel coronavirus disease.

Keywords:
COVID-19Drug repositioningIn silico drug discovery

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.9K

Related Experiment Videos

Last Updated: Dec 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.0K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.9K

Area of Science:

  • Virology
  • Pharmacology
  • Infectious Diseases

Background:

  • The emergence of COVID-19 has significantly impacted global health and daily life.
  • The absence of specific antiviral medications or vaccines necessitates urgent therapeutic strategies.
  • Traditional drug development is lengthy and expensive, highlighting the need for alternative approaches.

Purpose of the Study:

  • To introduce drug repurposing as a viable strategy for identifying COVID-19 treatments.
  • To discuss the methodologies employed in drug repurposing for emerging infectious diseases.
  • To outline the inherent challenges in the drug repurposing process for COVID-19.

Main Methods:

  • Literature review of drug repurposing strategies.
  • Analysis of existing drug databases and clinical trial data.
  • Exploration of computational and experimental methods for drug repurposing.

Main Results:

  • Drug repurposing can accelerate the identification of potential COVID-19 therapies.
  • Several existing drugs show promise for repurposing against SARS-CoV-2.
  • Significant challenges remain, including efficacy validation and regulatory hurdles.

Conclusions:

  • Drug repurposing presents a promising avenue for rapid COVID-19 therapeutic development.
  • Addressing the identified challenges is crucial for successful implementation of drug repurposing strategies.
  • Further research and collaboration are needed to optimize drug repurposing for future pandemics.